The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.56BCNY
380.26M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
336.93MCNY
50.10M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-23.53%
Updated Aug 21, 2026
Beta
0.8020x
vs all stocks
Updated Aug 21, 2026
52-Week Change
0.39%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
2.56BCNY
380.26M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
2.73BCNY
405.68M · vs all stocks (USD)
Updated Aug 21, 2026
Price to Sales (TTM)
7.68x
Updated Aug 21, 2026
Price to Book (MRQ)
5.28x
Updated Aug 21, 2026
Enterprise to Revenue
8.10x
Updated Aug 21, 2026
Gross Margin
50.52%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 38.25%.Updated Aug 21, 2026
Profit Margin
-23.53%
Updated Aug 21, 2026
Operating Margin
1.99%
Updated Aug 21, 2026
Return on Assets (TTM)
-2.61%
Updated Aug 21, 2026
Return on Equity (TTM)
-15.04%
Updated Aug 21, 2026
Revenue (TTM)
336.93MCNY
50.10M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
0.9540CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
-26.10%
Updated Aug 21, 2026
Gross Profit (TTM)
128.88MCNY
19.17M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
39.53MCNY
5.88M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-79.27MCNY
-11.79M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-26.12%
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-15.03MCNY
-2.24M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
0.00%
Updated Aug 21, 2026
Minority Interest (Equity)
160.20KCNYFY2025 · Dec 31, 2025
Revenue
363.42MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
179.67MCNYFY2025 · Dec 31, 2025
Gross Profit
183.75MCNYFY2025 · Dec 31, 2025
Operating Income
15.49MCNY
2.30M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-56.83MCNYFY2025 · Dec 31, 2025
Income Tax Expense
6.23MCNYFY2025 · Dec 31, 2025
Net Income
-63.06MCNYFY2025 · Dec 31, 2025
EBIT
-45.36MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
39.53MCNYFY2025 · Dec 31, 2025
Research & Development
2.10MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
56.12MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
30.03MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
22.16KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.46MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
331.89MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
331.89MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-63.06MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
0.00CNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-50.21MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-50.58MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
49.51MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-63.06MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
12.31MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-31.11MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
31.66MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-371.29KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-371.29KCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
143.80MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-117.70MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-9.82MCNYFY2025 · Dec 31, 2025
Other Financing Charges
9.76MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
26.04MCNYFY2025 · Dec 31, 2025
Shares Outstanding
332.08MSharesUpdated Aug 21, 2026
Float Shares
293.22MSharesUpdated Aug 21, 2026
% Held by Insiders
35.83%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
3.36%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
31.14MCNY
4.63M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
0.0940CNYUpdated Aug 21, 2026
Total Debt (MRQ)
218.56MCNY
32.50M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.4460x
Updated Aug 21, 2026
Current Ratio (MRQ)
1.32x
Updated Aug 21, 2026
Book Value per Share (MRQ)
1.48CNYUpdated Aug 21, 2026
Total Assets
986.32MCNY
146.68M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
513.95MCNYFY2025 · Dec 31, 2025
Total Liabilities
489.12MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
472.37MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
90.41MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
398.71MCNYFY2025 · Dec 31, 2025
Cash
49.51MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.97MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
53.47MCNYFY2025 · Dec 31, 2025
Accounts Receivable
13.91MCNYFY2025 · Dec 31, 2025
Inventory
383.56MCNYFY2025 · Dec 31, 2025
Accounts Payable
66.75MCNYFY2025 · Dec 31, 2025
Short-term Debt
149.06MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
69.04MCNYFY2025 · Dec 31, 2025
Long-term Debt
54.01MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
14.79MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
332.08MCNYFY2025 · Dec 31, 2025
Retained Earnings
-432.64MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
497.20MCNY
73.94M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.71CNYUpdated Aug 21, 2026
52-Week High
14.52CNYUpdated Aug 21, 2026
52-Week Change
0.39%
vs all stocks
Updated Aug 21, 2026
Beta
0.8020x
vs all stocks
Updated Aug 21, 2026
50-Day MA
7.76CNYUpdated Aug 21, 2026
200-Day MA
7.36CNYUpdated Aug 21, 2026
Avg 10-Day Volume
13.34MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
27.11MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.2400CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.51Profit Margin: -0.24
Financial Health
Altman Z-Score 2.88: safe zoneNotable
Altman Z-Score: 2.88
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.